Literature DB >> 27407154

Treatment of Stage IIIA Non-Small-Cell Lung Cancer: A Concise Review for the Practicing Oncologist.

Rafael Santana-Davila1, Renato Martins2.   

Abstract

Stage IIIA non-small-cell lung cancer occurs in a heterogenous group of patients for whom the best treatment is multimodality therapy with chemotherapy, radiation, and surgery in a select group of individuals. This clinical review intends to answer the most common questions that clinicians face in the decision about the best management in this group.
Copyright © 2016 by American Society of Clinical Oncology.

Entities:  

Mesh：

Year:  2016        PMID： 27407154     DOI： 10.1200/JOP.2016.013052

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


  6 in total

1.  Quantitative analysis and clonal characterization of T-cell receptor β repertoires in patients with advanced non-small cell lung cancer treated with cancer vaccine.

Authors:  Tu Mai; Atsushi Takano; Hiroyuki Suzuki; Takashi Hirose; Takahiro Mori; Koji Teramoto; Kazuma Kiyotani; Yusuke Nakamura; Yataro Daigo
Journal:  Oncol Lett       Date:  2017-05-05       Impact factor: 2.967

Review 2.  Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time?

Authors:  Elizabeth Ahern; Ben J Solomon; Rina Hui; Nick Pavlakis; Ken O'Byrne; Brett G M Hughes
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

3.  Low Dose Naltrexone and Lung Cancer: A Case Report and Discussion.

Authors:  Jeffrey A Miskoff; Moiuz Chaudhri
Journal:  Cureus       Date:  2018-07-05

4.  Melittin suppresses growth and induces apoptosis of non-small-cell lung cancer cells via down-regulation of TGF-β-mediated ERK signal pathway.

Authors:  Renzhi Yu; Miao Wang; Minghuan Wang; Lei Han
Journal:  Braz J Med Biol Res       Date:  2020-12-18       Impact factor: 2.590

5.  Spontaneous regression of locally advanced nonsmall cell lung cancer: A case report.

Authors:  Kiat Huat Ooi; Timothy Cheo; Gwyneth Shook Ting Soon; Cheng Nang Leong
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

6.  Lobectomy Versus Sublobectomy in Stage IIIA/N2 Non-Small Cell Lung Cancer: A Population-Based Study.

Authors:  Suyu Wang; Zhiyuan Zhang; Yang Gu; Xin Lv; Xuan Shi; Meiyun Liu
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.